Digital Ulcers Linked to More Severe Systemic Sclerosis PDF Print E-mail
Sunday, 23 January 2011 10:46
Digital ulcers are associated with more severe systemic sclerosis (SSc) disease, including skin and lung involvement, but not with pulmonary arterial hypertension (PAH) or scleroderma renal crisis (SRC), according to research published in the January issue of Arthritis Care & Research.

Sarit Khimdas, from the University of Western Ontario in London, Canada, and colleagues analyzed data from 938 patients with SSc who participated in the Canadian Scleroderma Research Group, which collects information from SSc patients annually. Data included the presence, position, and number of digital ulcers; complications; involvement of internal organs; skin score; and results from laboratory testing.

The investigators found that 8 percent of patients currently had a digital ulcer; 44 percent had had one in the past; and 53.1 percent had digital pitting scars. In limited cutaneous SSc and diffuse cutaneous SSc subsets, digital ulcers were associated with a higher disease burden, as evidenced by higher Rodnan skin scores, hand and finger scores, and worse hand function according to the Health Assessment Questionnaire score. Digital ulcers were also linked to longer disease duration, younger age at disease onset, interstitial lung disease, and topoisomerase I antibodies. No association was seen with sex, smoking, PAH, or SRC. In diffuse cutaneous SSc, digital ulcers were associated with reduced diffusing capacity for carbon monoxide and esophageal involvement.

"In conclusion, there are some associations with digital ulcers but a surprising lack of association between digital ulcers and other manifestations of structural vasculopathy, including PAH and SRC," the authors write.

Source: DoctorsLounge. Original article can be viewed here.
 
More articles :

» Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?

Eric Hachulla, MD, PhD; David Launay, MD, PhD; Luc Mouthon, MD, PhD; Olivier Sitbon, MD, PhD; Alice Berezne, MD; Loïc Guillevin, MD; Pierre-Yves Hatron, MD; Ge´rald Simonneau, MD; Pierre Clerson, MD; and Marc Humbert, MD, PhD;Pulmonary arterial...

» Biomarkers Predict Lung Decline in Systemic Sclerosis

Predicting risk of pulmonary fibrosis and pulmonary hypertension is an urgent priority in systemic sclerosis. Lung function often declines rapidly in the first years after diagnosis, and interstitial lung disease (ILD), although highly variable in...

» A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis

T. W. van Hal, L. van Bon, and T. R. D. J. RadstakeReceived 20 May 2011; Revised 18 August 2011; Accepted 7 September 2011Systemic sclerosis (SSc) is typified by vascular alterations and immunological disturbances and fibrosis of the skin and...

» Quality Indicator Sets For Scleroderma

Despite the increasing awareness of Scleroderma (SSc), it continues to have a detrimental effect of the quality of health and lives of those with it. The medical community has recognized that although early treatment of can have a substantial...

» The Imbalanced Expression of Matrix Metalloproteinases in Nephrogenic Systemic Fibrosis

Brent C. Kelly, MD, Leslie Scroggins Markle, MD, Jennifer L. Vickers, MD, Matthew S. Petitt, DO, Sharon S. Raimer, MD, and Catherine McNeese, MDBackground: Nephrogenic systemic fibrosis (NSF) occurs in patients with renal dysfunction and gadolinium...

» The American College of Rheumatology Issues Guidelines for Management of Lupus Nephritis

The American College of Rheumatology (ACR) has issued newly created guidelines for the screening, treatment, and management of lupus nephritis—a severe manifestation of systemic lupus erythematosus (SLE) where the disease attacks the kidneys....